Article metrics
Regular and Young Investigator Award Abstracts
Biomarkers, Immune Monitoring and Novel Technologies
167 Increased programmed cell death 1 ligand 2 (PD-L2) protein and transcript levels in triple negative breast cancer patients improve prognostic value through immune pathway activation
